
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.(KYMR)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kymr · 股价预测 · 26 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 26 位华尔街分析师
Buy
26 位分析师
共识
评级分布
12 个月目标价
High
$138
Consensus
$120
+61.9% upside
Low
$106
Median: $119.5 · Last Close: $74.34
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$120.36
61.9% upside
High Target
$138
85.6%
Low Target
$106
42.6%
Current Price
$74.34
as of today
Based on analyst price targets, the KYMR stock price prediction for the next 12 months ranges from $106 to $138. The consensus KYMR price forecast of $120.36 implies 61.9% upside from the current price of $74.34.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $70.62 | ↓ 5.00% |
1-day model range: $70.27–$70.98. Peak: $70.98 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KYMR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-03 | UBS | Maintains | Buy→Buy |
| 2026-03-02 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-03-02 | Citigroup | Maintains | Buy→Buy |
| 2026-02-26 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-02-26 | BTIG | Maintains | Buy→Buy |
| 2026-02-03 | BTIG | Maintains | Buy→Buy |
| 2026-01-28 | Barclays | Maintains | Overweight→Overweight |
| 2026-01-15 | BTIG | Maintains | Buy→Buy |
| 2026-01-06 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2025-12-22 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kymera Therapeutics, Inc. (KYMR) stock. Of the recent 117 rating actions, 6 were upgrades and 4 were downgrades. 26 analysts currently cover KYMR.
分析师推荐趋势
KYMR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 3 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$80M
↑ 103.3% YoY
Revenue Next Year
$39M
↓ 50.7% YoY
EPS This Year
$-3.50
EPS Next Year
$-4.30
↑ 22.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast KYMR EPS of $-3.50 for the current fiscal year, based on estimates from 17 analysts. The KYMR revenue forecast is $80M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KYMR 股价预测由两类独立数据源支撑:来自 26 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。KYMR 的共识目标价为 $120.36(+61.9% 上行空间),分析师共识为 Buy。
KYMR 的短期预测(明日)为 $70.62(-5.00%)。
Kymera Therapeutics, Inc. 在 NASDAQ 上市,代码 KYMR。KYMR 在 2027 年的整体展望偏积极,在覆盖分析师中约 88% 对应 Buy 共识。
常见问题
KYMR 预测 · 8 个问题根据 26 位华尔街分析师,KYMR 的 12 个月平均目标价为 $120.36,最高 $138.00、最低 $106.00。若有图表,中位目标价可在上方查看。相对当前价 $74.34,隐含约 +61.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.